Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 51, 2016 - Issue 11
Submit an article Journal homepage
123
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death

Synne SembGastro Unit, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark; Correspondence[email protected]
,
Søren NeermarkGastro Unit, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark; ;National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark;
,
Sanne Dam-LarsenDepartment of Medicine, Zealand University Hospital, Køge, Denmark;
,
Maria Benedicte FranzmannDepartment of Pathology, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark;
,
Jens AlbrectsenDepartment of Pathology, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark;
,
Thomas KallemoseClinical Research Center, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark; ;Department of Orthopedic Surgery, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark
,
Ulrik BeckerGastro Unit, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark; ;National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark;
&
Flemming BendtsenGastro Unit, Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark;
show all
Pages 1367-1374 | Received 25 Apr 2016, Accepted 14 Jun 2016, Published online: 05 Jul 2016

References

  • Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology. 2011;141:1572–1585.
  • Dam-Larsen S. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004;53:750–755.
  • Dam-Larsen S, Franzmann M-B, Christoffersen P, et al. Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol. 2005;40:460–467.
  • Dam-Larsen S, Becker U, Franzmann M-B, et al. Final results of a long-term, clinical follow-up in fatty liver patients. Scand J Gastroenterol. 2009;44:1236–1243.
  • Sørensen TI, Orholm M, Bentsen KD, et al. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet. 1984;2:241–244.
  • Teli MR, Day CP, Burt AD, et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet. 1995;346:987–990.
  • Deleuran T, Grønbaek H, Vilstrup H, et al. Cirrhosis and mortality risks of biopsy-verified alcoholic pure steatosis and steatohepatitis: a nationwide registry-based study. Aliment Pharmacol Ther. 2012;35:1336–1342.
  • Mathurin P, Beuzin F, Louvet A, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther. 2007;25:1047–1054.
  • Semb S, Dam-Larsen S, Mogensen AM, et al. Low incidence of non-alcoholic steatohepatitis in a Danish liver unit. Dan Med J. 2012;59:A4354.
  • Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39:30–33.
  • Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39:26–29.
  • Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39:72–74.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383.
  • EASL clinical practical guidelines: management of alcoholic liver disease. J Hepatol. 2012;57:399–420.
  • Baptista A, Bianchi L, De Groote J, et al. Alcoholic liver disease: morphological manifestations. Lancet. 1981;317:707–711.
  • Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474.
  • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321.
  • Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis. 2005;9:37–53.
  • Pohar M, Stare J. Making relative survival analysis relatively easy. Comput Biol Med. 2007;37:1741–1749.
  • Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–526.
  • R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. 2015. Available from: https://www.R-project.org/.
  • Bendtsen F, Dam-Larsen S. Long-term, clinical follow-up in fatty liver patients. Dig Dis. 2010;28:709–714.
  • Ekstedt M, Hagström H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547–1554.
  • Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389–397.
  • Hansen N, Hay G, Cowan S, et al. Hepatitis B prevalence in Denmark – an estimate based on nationwide registers and a national screening programme, as on 31 December 2007. Euro Surveill. 2013;18. doi:10.2807/1560-7917.ES2013.18.47.20637.
  • Christensen PB, Hay G, Jepsen P, et al. Hepatitis C prevalence in Denmark – an estimate based on multiple national registers. BMC Infect Dis. 2012;12:178.
  • Vestberg K, Thulstrup AM, Sørensen HT, et al. Data quality of administratively collected hospital discharge data for liver cirrhosis epidemiology. J Med Syst. 1997;21:11–20.
  • Askgaard G, Grønbæk M, Kjær MS, et al. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study. J Hepatol. 2015;62:1061–1067.
  • Marbet UA, Bianchi L, Meury U, et al. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol. 1987;4:364–372.
  • Kamper-Jørgensen M, Grønbaek M, Tolstrup J, et al. Alcohol and cirrhosis: dose-response or threshold effect? J Hepatol. 2004;41:25–30.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.